CXCL9 and neoplasm: This demonstrated significantly higher expression of CXCL9 and CXCL10 for the anti-tumor immune-suppressive M2 tumor-related macrophage family than for the M1 macrophage (p = 6 × 10−27, 8 × 10−6, respectively) (Figure 4F).